NIOSH logo and tagline

Persistence of SARS-CoV-2 on N95 filtering facepiece respirators: implications for reuse

Updated July 23, 2024

July 2024
NIOSH Dataset RD-1088-2024-0

Introduction

In response to the shortage of N95® filtering facepiece respirators (FFRs) for healthcare workers during the COVID-19 pandemic, the Centers for Disease Control and Prevention (CDC) issued strategies for extended use and limited reuse of N95 FFRs to conserve supply. Previously worn N95 FFRs can serve as a source of pathogens, which can be transferred to the wearer while doffing and donning a respirator when practicing reuse. To reduce the risk of self-contamination when donning and doffing reused FFRs, the CDC suggested storing FFRs for five days between uses to allow for the decay of viable pathogens including SARS-CoV-2. This study assessed the persistence of the SARS-CoV-2 strain USA-WA1/2020 on N95 FFRs under controlled storage conditions for up to five days to inform the CDC guidance.

Methods Collection

Virus propagation

  • Virus used: Severe Acute Respiratory Syndrome (SARS)-Coronavirus CoV-2 strain USA-WA1/2020 (WA1), obtained from BEI Resources (Manassas, VA).
  • Working stocks had titers of approximately 106 tissue-culture infectious doses 50% [TCID50] per milliliter.
  • Material stored as single-use vials at ≤ -80⁰

Test coupons

  • Six NIOSH Approved® FFR models
    • Four NIOSH Approved and FDA-cleared Surgical N95 FFRs
      • 3M 1860 and VFlex 1804
      • Moldex 1512 and 2200
    • Two NIOSH Approved N95 FFRs
      • 3M 8210 and 8511
    • Non-porous controls – glass coupons (microscope cover slides)
    • Rectangular coupons (2×5 cm) taken from unused FFRs.

Coupon contamination and storage conditions

  • Virus suspended in
    • Complete cell culture medium
    • Human saliva
  • Ten droplets (10 µL each droplet) applied to coupons under ambient conditions (20⁰C–22⁰C and 30%–50% RH).
  • Total deposition of SARS-CoV-2 was approximately 1×105 TCID50 across the outer surface of the FFR coupon.
  • Coupons were allowed to dry under ambient conditions.
  • Transferred to brown paper bags and stored at 20⁰C–22⁰C and at 20% (15%–25%), 45% (30%–50%), and 75% (70%–75%) RH.
  • Virus on the FFR coupons and glass slides were extracted after 0- , 1- , 24- , 48- , 96- , and 120-hr timepoints.
    • Additional assessments were performed after 4- , 6- , and 12-hr post-drying when more data points were needed.
    • Virus persistence was evaluated in triplicate for each tested surface, timepoint, and condition.
  • Some conditions were not tested for all FFR models due to limited supply.

Virus extraction and analysis

  • Coupons were removed from the paper bags and placed into individual 50-mL conical tubes containing a 10-mL extraction buffer.
  • Starting volume was concentrated to approximately 0.5 mL.
  • Media was added to equilibrate all washed retentates to approximately 2 mL.
  • Virus viability was assessed by TCID50 assay in Vero E6 cells.
    • Samples inoculated in quintuplicate onto a single 96-well plate at 70% cell monolayer confluency.
    • Plates were incubated at 37 ± 2⁰C and 5 ± 2% carbon dioxide for 72 ± 4 hr.
    • Observed microscopically for cytopathic effects (CPE, visible morphological changes in cell cultures caused by viral infections).
    • Used to quantitatively calculate the viral titer for each sample.
  • Extraction efficiency was assessed relative to a direct spiking and quantification of the extraction medium for
    • NIOSH Approved and FDA-cleared surgical N95 FFR (3M 1860)
    • NIOSH Approved N95 FFR (3M 8511)
    • Glass control surface

Citations – Publications based on this dataset:

Fisher EM; Kuhlman MR; Choi YW; Jordan TL; Sunderman M. Persistence of SARS-Co-V-2 on N95 filtering facepiece respirators: implications for reuse. J Occup Environ Hyg 2021 Dec; 18(12):570-578, DOI: 10.1080/15459624.2021.1985727.

Acknowledgements

This work was supported by the Centers for Disease Control and Prevention’s (CDC) National Institute for Occupational Safety and Health (NIOSH).

Edward M. Fisher, efisher@cdc.gov

Michael R. Kuhlman, kuhlmanm@battelle.org

Young W. Choi, choiy@battelle.org

Traci L. Jordan, jordant@battelle.org

Michelle Sunderman, sunderman@battelle.org

Contact

For further information contact:

Research Branch (RB)
National Personal Protective Technology Laboratory (NPPTL)
National Institute for Occupational Safety and Health (NIOSH)
626 Cochrans Mill Road
Pittsburgh, PA 15236
ODAdmin@cdc.gov